We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+11.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79B
AUM Growth
+$5.52B
Cap. Flow
-$7.01B
Cap. Flow %
-8.87%
Top 10 Hldgs %
24.46%
Holding
2,559
New
284
Increased
737
Reduced
832
Closed
260

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$555M
2
AEP icon
American Electric Power
AEP
+$272M
3
ULTA icon
Ulta Beauty
ULTA
+$161M
4
CVS icon
CVS Health
CVS
+$160M
5
MCD icon
McDonald's
MCD
+$139M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$388M
2
AON icon
Aon
AON
+$211M
3
JNJ icon
Johnson & Johnson
JNJ
+$209M
4
NSC icon
Norfolk Southern
NSC
+$162M
5
NVST icon
Envista
NVST
+$149M

Sector Composition

Rank Sector Weight
1 Technology 20.99%
2 Financials 14.12%
3 Healthcare 13.38%
4 Industrials 11.48%
5 Consumer Discretionary 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIO icon
2001
Bio-Rad Laboratories Class A
BIO
$9.12B
$1K ﹤0.01%
4
BTBT icon
2002
Bit Digital
BTBT
$482M
$1K ﹤0.01%
274
CCOI icon
2003
Cogent Communications
CCOI
$540M
$1K ﹤0.01%
22
CDRE icon
2004
Cadre Holdings
CDRE
$1.56B
$1K ﹤0.01%
31
-3,321
-99% -$100K
CEG icon
2005
Constellation Energy
CEG
$95.3B
$1K ﹤0.01%
13
CNXN icon
2006
PC Connection
CNXN
$2.19B
$1K ﹤0.01%
+15
New +$892
CSGP icon
2007
CoStar Group
CSGP
$12B
$1K ﹤0.01%
22
-5,330
-100% -$431K
CTMX icon
2008
CytomX Therapeutics
CTMX
$731M
$1K ﹤0.01%
+1,251
New +$1.65K
CTSO icon
2009
Cytosorbents Corp
CTSO
$25.1M
$1K ﹤0.01%
+938
New +$1.39K
DASH icon
2010
DoorDash
DASH
$92.5B
$1K ﹤0.01%
12
EAF icon
2011
GrafTech
EAF
$201M
$1K ﹤0.01%
72
ELAN icon
2012
Elanco Animal Health
ELAN
$12B
$1K ﹤0.01%
103
ELS icon
2013
Equity Lifestyle Properties
ELS
$12.6B
$1K ﹤0.01%
15
EML icon
2014
Eastern Company
EML
$151M
$1K ﹤0.01%
+46
New +$860
ENTG icon
2015
Entegris
ENTG
$22B
$1K ﹤0.01%
13
EPAC icon
2016
Enerpac Tool Group
EPAC
$1.92B
$1K ﹤0.01%
+60
New +$1.71K
GNRC icon
2017
Generac Holdings
GNRC
$12.6B
$1K ﹤0.01%
14
+4
+40% +$439
HOOD icon
2018
Robinhood
HOOD
$81.8B
$1K ﹤0.01%
102
+47
+85% +$467
JAZZ icon
2019
Jazz Pharmaceuticals
JAZZ
$16.9B
$1K ﹤0.01%
11
KN icon
2020
Knowles
KN
$3.41B
$1K ﹤0.01%
+56
New +$870
KVHI icon
2021
KVH Industries
KVHI
$157M
$1K ﹤0.01%
+230
New +$1.12K
LAKE icon
2022
Lakeland Industries
LAKE
$118M
$1K ﹤0.01%
+58
New +$892
LECO icon
2023
Lincoln Electric
LECO
$15.2B
$1K ﹤0.01%
8
-1,508
-99% -$291K
MASI
2024
DELISTED
Masimo
MASI
$1K ﹤0.01%
10
MKTX icon
2025
MarketAxess Holdings
MKTX
$5.72B
$1K ﹤0.01%
6
+3
+100% +$726

Similar funds

Lazard Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Lazard Asset Management held 2,559 positions worth $79B, up 7.5% from $73.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Lazard Asset Management withdrew a net $7.01B in Q4 2023, closing 260 positions and reducing 832 holdings. Its most notable exit was VMware, Inc, an estimated $34.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Dentsply Sirona worth $141M.

  • Lazard Asset Management's largest Q4 2023 buy was Dentsply Sirona: 3,954,444 shares worth $141M.
  • Lazard Asset Management added most to Chubb in Q4 2023, an estimated $555M increase.
  • Lazard Asset Management's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $388M.
  • Lazard Asset Management fully exited VMware, Inc in Q4 2023, selling an estimated $34.5M.
  • Lazard Asset Management's ten largest holdings make up 24% of its $79B portfolio in Q4 2023.
  • Lazard Asset Management opened 284 new positions and closed 260 in Q4 2023.
  • Lazard Asset Management's portfolio value rose 7.5% quarter-over-quarter to $79B.

Based on Lazard Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.